Targeted platelet inhibition with a bispecific antibody fragment that binds to platelet glycoprotein Iib/IIIa receptor and tissue factor : prevention of thombosis after angioplasty with a new locally delivered bispecific antibody against tissue factor and platelet glycoprotein IIb/IIIa receptor